Table 2.
Regional estimates of hepatitis C virus seroprevalence and viraemia
| Regions | Anti-HCV prevalence (%) | Viraemic rate (%) |
| Central Sub-Saharan Africa | 6.0 | 68.5 |
| EastSub-Saharan Africa | 2.4 | 65.0 |
| Southern Sub-Saharan Africa | 0.9 | 69.0 |
| WestSub-Saharan Africa | 2.4 | 79.6 |
| North Africa and Middle East | 2.7 | 68.8 |
| North America, High Income | 1.2 | 75.7 |
| Caribbean | 1.5 | 70.0 |
| Andean Latin America | 1.2 | 70.0 |
| Central Latin America | 1.4 | 75.8 |
| Southern Latin America | 1.5 | 79.5 |
| Tropical Latin America | 1.6 | 80.2 |
| Central Asia | 5.8 | 48.7 |
| East Asia | 2.8 | 63.6 |
| Pacific Asia, High-income | 1.1 | 70.5 |
| South Asia | 2.5 | 78.5 |
| Southeast Asia | 1.6 | 60.5 |
| Australasia | 1.8 | 74.8 |
| Europe, Central | 1.3 | 76.6 |
| Europe, Eastern | 3.1 | 69.6 |
| Europe, Western | 0.9 | 71.0 |
HCV: Hepatitis C virus.